Sponsor Dossier
Atnahs Pharma
Sponsor Dossier for Atnahs Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ANAPROX
- Brand: BONDRONAT
- Brand: CRYSANAL
- Brand: DIPENTUM
- Brand: ELOVAX
- Brand: FAMVIR
- Brand: FRISIUM
- Brand: INDERAL
About
Atnahs Pharma is an Australian Private Company with ABN 50169865187, registered in NSW and currently active.
Portfolio
Atnahs Pharma has 22 brands on the ARTG, of which 21 are indexable and 20 carry a Product Information document. 18 brands are PBS-listed, 5 have a PBAC outcome on record, and 2 have an AusPAR on record. Notable brands include ANAPROX, BONDRONAT, CRYSANAL, DIPENTUM, ELOVAX, FAMVIR, FRISIUM, INDERAL, KYTRIL, LEUSTATIN, NAPROSYN, PROXEN.
Therapeutic focus
— Neurology: 5 brands — Musculoskeletal: 3 brands — Cardiology: 3 brands — Oncology: 3 brands — Psychiatry: 2 brands — Pain Management: 2 brands — Infectious Disease: 2 brands — Endocrinology: 1 brand — Gastroenterology: 1 brand
PBS footprint
18 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2021-03-01, across 5 brands with a PBAC outcome on record. The latest AusPAR is 2021-06-28, across 2 brands with an AusPAR on record.